84 related articles for article (PubMed ID: 8497428)
21. In-silico modeling studies of G-quadruplex with soy isoflavones having anticancerous activity.
Tomar JS
J Mol Model; 2015 Aug; 21(8):193. PubMed ID: 26164556
[TBL] [Abstract][Full Text] [Related]
22. Design, Synthesis, and Evaluation of Genistein Analogues as Anti-Cancer Agents.
Xiong P; Wang R; Zhang X; DeLa Torre E; Leon F; Zhang Q; Zheng S; Wang G; Chen QH
Anticancer Agents Med Chem; 2015; 15(9):1197-203. PubMed ID: 25991428
[TBL] [Abstract][Full Text] [Related]
23. Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals.
Kadioglu O; Cao J; Saeed ME; Greten HJ; Efferth T
Target Oncol; 2015 Sep; 10(3):337-53. PubMed ID: 25410594
[TBL] [Abstract][Full Text] [Related]
24. Molecular cloning and characterization of genistein 4'-O-glucoside specific glycosyltransferase from Bacopa monniera.
Ruby ; Santosh Kumar RJ; Vishwakarma RK; Singh S; Khan BM
Mol Biol Rep; 2014 Jul; 41(7):4675-88. PubMed ID: 24664316
[TBL] [Abstract][Full Text] [Related]
25. Perspectives on the role of isoflavones in prostate cancer.
Ahmad A; Biersack B; Li Y; Bao B; Kong D; Ali S; Banerjee S; Sarkar FH
AAPS J; 2013 Oct; 15(4):991-1000. PubMed ID: 23824838
[TBL] [Abstract][Full Text] [Related]
26. Isoflavones: estrogenic activity, biological effect and bioavailability.
Vitale DC; Piazza C; Melilli B; Drago F; Salomone S
Eur J Drug Metab Pharmacokinet; 2013 Mar; 38(1):15-25. PubMed ID: 23161396
[TBL] [Abstract][Full Text] [Related]
27. Aggressive prostate cancer is prevented in ERαKO mice and stimulated in ERβKO TRAMP mice.
Slusarz A; Jackson GA; Day JK; Shenouda NS; Bogener JL; Browning JD; Fritsche KL; MacDonald RS; Besch-Williford CL; Lubahn DB
Endocrinology; 2012 Sep; 153(9):4160-70. PubMed ID: 22753646
[TBL] [Abstract][Full Text] [Related]
28. Measurement of bisphenol A, bisphenol A ß-D-glucuronide, genistein, and genistein 4'-ß-D-glucuronide via SPE and HPLC-MS/MS.
Coughlin JL; Winnik B; Buckley B
Anal Bioanal Chem; 2011 Aug; 401(3):995-1002. PubMed ID: 21667348
[TBL] [Abstract][Full Text] [Related]
29. The cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor α protein.
Fiori JL; Sanghvi M; O'Connell MP; Krzysik-Walker SM; Moaddel R; Bernier M
Br J Pharmacol; 2011 Oct; 164(3):1026-40. PubMed ID: 21449913
[TBL] [Abstract][Full Text] [Related]
30. Anti-anxiety, cognitive, and steroid biosynthetic effects of an isoflavone-based dietary supplement are gonad and sex-dependent in rats.
Friedman J; Frye C
Brain Res; 2011 Mar; 1379():164-75. PubMed ID: 21167133
[TBL] [Abstract][Full Text] [Related]
31. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals.
Gupta SC; Kim JH; Prasad S; Aggarwal BB
Cancer Metastasis Rev; 2010 Sep; 29(3):405-34. PubMed ID: 20737283
[TBL] [Abstract][Full Text] [Related]
32. Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers.
Tanaka M; Fujimoto K; Chihara Y; Torimoto K; Yoneda T; Tanaka N; Hirayama A; Miyanaga N; Akaza H; Hirao Y
Prostate Cancer Prostatic Dis; 2009; 12(3):247-52. PubMed ID: 19597532
[TBL] [Abstract][Full Text] [Related]
33. [A critical assessment of phytotherapy for prostate cancer].
Perabo FG; von Löw EC; Siener R; Ellinger J; Müller SC; Bastian PJ
Urologe A; 2009 Mar; 48(3):270-1, 274-83. PubMed ID: 19153707
[TBL] [Abstract][Full Text] [Related]
34. Endocrine-immune-paracrine interactions in prostate cells as targeted by phytomedicines.
Gray NE; Liu X; Choi R; Blackman MR; Arnold JT
Cancer Prev Res (Phila); 2009 Feb; 2(2):134-42. PubMed ID: 19141600
[TBL] [Abstract][Full Text] [Related]
35. Estrogenic and Acetylcholinesterase-Enhancement Activity of a New Isoflavone, 7,2',4'-Trihydroxyisoflavone-4'-O-beta-D-Glucopyranoside from Crotalaria Sessililflora.
Mun'im A; Isoda H; Seki M; Negishi O; Ozawa T
Cytotechnology; 2003 Nov; 43(1-3):127-34. PubMed ID: 19003217
[TBL] [Abstract][Full Text] [Related]
36. Multi-targeted therapy of cancer by genistein.
Banerjee S; Li Y; Wang Z; Sarkar FH
Cancer Lett; 2008 Oct; 269(2):226-42. PubMed ID: 18492603
[TBL] [Abstract][Full Text] [Related]
37. Genistein chemoprevention of prostate cancer in TRAMP mice.
Wang J; Eltoum IE; Lamartiniere CA
J Carcinog; 2007 Mar; 6():3. PubMed ID: 17367528
[TBL] [Abstract][Full Text] [Related]
38. Complementary medicine for prostate cancer: effects of soy and fat consumption.
Moyad MA; Sakr WA; Hirano D; Miller GJ
Rev Urol; 2001; 3 Suppl 2(Suppl 2):S20-30. PubMed ID: 16985997
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones.
Puli S; Lai JC; Bhushan A
J Neurooncol; 2006 Sep; 79(2):135-42. PubMed ID: 16598420
[TBL] [Abstract][Full Text] [Related]
40. Flavonoid compounds in maintenance of prostate health and prevention and treatment of cancer.
Brown DM; Kelly GE; Husband AJ
Mol Biotechnol; 2005 Jul; 30(3):253-70. PubMed ID: 15988050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
